Search alternatives:
marked decrease » marked increase (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
day mean » may mean (Expand Search), daily mean (Expand Search), data mean (Expand Search)
Showing 1 - 20 results of 977 for search '(( third ((((larger decrease) OR (nn decrease))) OR (marked decrease)) ) OR ( day mean decrease ))', query time: 0.69s Refine Results
  1. 1
    Individual and mean EQ-5D VAS scores in the PP-group (0 = baseline, 1 = after the first day of treatment, 2 = after the second day of treatment, 3 = after the third day of treatment, 4 = after the fourth day of treatment, 5 = after all treatments, 35 = at the 30-day follow-up).

    Individual and mean EQ-5D VAS scores in the PP-group (0 = baseline, 1 = after the first day of treatment, 2 = after the second day of treatment, 3 = after the third day of treatmen... by Marcus Persson (20496333)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Top: Individual Montgomery-Åsberg Depression Rating Scale (MADRS) scores in the PP-group.

    Top: Individual Montgomery-Åsberg Depression Rating Scale (MADRS) scores in the PP-group. by Marcus Persson (20496333)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Average days (mean) to heal a wound in 2022 and 2023.

    Average days (mean) to heal a wound in 2022 and 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Association between the mean of the daily mean temperatures for the previous 7 days and AAD onset by subset analysis.

    Association between the mean of the daily mean temperatures for the previous 7 days and AAD onset by subset analysis. by Ayami Ishikawa (19838027)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 5
    Cronbach’s alpha and means the stigma of Suicide Scale Short Form (SOSS-SF).

    Cronbach’s alpha and means the stigma of Suicide Scale Short Form (SOSS-SF). by Orrin D. Ware (14829115)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90.

    Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  7. 7
    Antibody and antigen responses to Ensovibep vs placebo day 1–90.

    Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  8. 8
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  9. 9
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  10. 10
    Mean cocaine consumed (mg/kg) over 10 days.

    Mean cocaine consumed (mg/kg) over 10 days. by Christopher Rowan (21499924)

    Published 2025
    Save to List
    Saved in:
  11. 11
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  12. 12
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  13. 13
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  14. 14
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time.

    Geometric mean anti-<i>Na</i>-GST-1 IgG subclass levels over time. by David J. Diemert (8135568)

    Published 2024
    Save to List
    Saved in:
  16. 16
    Fluctuation trend of the mean temperature index.

    Fluctuation trend of the mean temperature index. by Chengyuan Hao (21615653)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Variation curve of the mean temperature index.

    Variation curve of the mean temperature index. by Chengyuan Hao (21615653)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Mann-Kendall test for the mean temperature index.

    Mann-Kendall test for the mean temperature index. by Chengyuan Hao (21615653)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Comparison of mean days of wound healing across different wound types by healing durations in 2022 and 2023.

    Comparison of mean days of wound healing across different wound types by healing durations in 2022 and 2023. by Heba Tallah Mohammed (2822432)

    Published 2025
    Save to List
    Saved in:
  20. 20
    Adjusted mean length of stay stratified by Admission Day and COVID period.

    Adjusted mean length of stay stratified by Admission Day and COVID period. by Rajkumar Rajendram (22505442)

    Published 2025
    Save to List
    Saved in:

Search Tools: